PPARD and primary biliary cholangitis: ,10,11,12,13 In the liver, a central organ of metabolism, PPARD is also attracting attention as a new therapeutic target,14,15 and a series of very promising clinical trial results of its agonists have recently been reported for patients with primary biliary cholangitis (PBC).16